The abstract submission for TAT 2022 is now closed!
Accepted abstracts are available online
Abstract submission deadline
Abstracts |
10 January 2022, 21:00 CET (Central European Time) |
---|
Outcome notifications
Outcome notifications are expected to be made available to first authors by end-January 2022.
Abstract submission categories
- Immunotherapy
- Kinase-targeting agents and cell signalling modulators
- Antibody-based therapies
- Epigenetics
- DNA damage repair
- Miscellaneous
Presentation and publication of abstracts accepted for the TAT 2022
The TAT 2022 Scientific Committee will select abstracts for presentation during the Congress and determine the format of the presentations from the following possibilities:
- Proffered Paper – Oral presentations by authors presenting original data of superior quality, followed by expert discussion and perspectives.
- Mini Oral – Short oral presentations by authors presenting data of good quality, followed by expert discussion and perspectives.
- Poster – Display sessions for review, discussion and questions. Presenting authors must be available for Q&A for one hour to represent their work.
All accepted abstracts will be published as a supplement to the official ESMO journal, Annals of Oncology.
Publication schedule for accepted abstracts
- Abstracts accepted for presentation at TAT 2022 as Poster will be published online on the ESMO website at 12:00 CET on Thursday, 3 March 2022.
- Abstracts accepted for presentation at TAT 2022 as Proffered Paper (oral presentation) and Mini Oral will be published online on the ESMO website at 12:00 CET on Monday, 7 March 2022.
- The publication schedule of abstracts with a different release will be available 10 days before the Congress.
Abstracts |
Date and time |
---|---|
Abstracts accepted as:
|
Thursday, 3 March 2022 |
Abstracts accepted as:
|
Monday, 7 March 2022 |
Abstracts with a different release schedule or with suffix _PR |
Schedule will be available 10 days before the Congress |
Travel Grants
A restricted number of travel grants to TAT 2022 are available, upon application, to first author (= presenter) of candidates under the age of 40 who submit abstracts considered deserving of recognition. Selection will be made by the TAT 2022 Scientific Committee on a competitive basis from among the accepted abstracts.